Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 |
|
Neoplasms | 0.710 | 1.000 | 3 | 2015 | 2018 | |||||||
|
0.724 | 0.400 | 5 | 1279913 | intron variant | G/A | snv | 0.18 |
|
Neoplasms; Male Urogenital Diseases | 0.710 | 1.000 | 3 | 2011 | 2018 | |||||||
|
0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.710 | 1.000 | 2 | 2016 | 2017 | |||||||
|
0.724 | 0.400 | 5 | 1279913 | intron variant | G/A | snv | 0.18 |
|
Neoplasms; Male Urogenital Diseases | 0.710 | 1.000 | 2 | 2011 | 2013 | |||||||
|
0.724 | 0.400 | 5 | 1279913 | intron variant | G/A | snv | 0.18 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.710 | 1.000 | 2 | 2013 | 2016 | |||||||
|
0.790 | 0.160 | 5 | 1282204 | intron variant | C/A | snv | 0.29 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.710 | 1.000 | 2 | 2015 | 2016 | |||||||
|
0.851 | 0.120 | 5 | 1254395 | missense variant | C/T | snv | 5.2E-05 | 9.1E-05 |
|
0.700 | 1.000 | 5 | 2005 | 2012 | |||||||
|
0.925 | 0.040 | 5 | 1272196 | missense variant | C/T | snv | 9.0E-05 | 1.5E-04 |
|
0.700 | 1.000 | 5 | 2005 | 2012 | |||||||
|
1.000 | 5 | 1294378 | missense variant | C/T | snv | 5.4E-06 |
|
0.700 | 1.000 | 5 | 2005 | 2012 | |||||||||
|
0.882 | 0.120 | 5 | 1294282 | missense variant | C/T | snv | 3.2E-04 | 1.8E-04 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 4 | 2005 | 2009 | ||||||
|
0.882 | 0.120 | 5 | 1279341 | missense variant | C/T | snv | 7.0E-06 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 4 | 2005 | 2009 | |||||||
|
1.000 | 0.040 | 5 | 1272213 | missense variant | G/A;C;T | snv | 4.0E-06; 1.2E-05 |
|
Hemic and Lymphatic Diseases | 0.700 | 1.000 | 4 | 2005 | 2009 | |||||||
|
0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 |
|
Neoplasms | 0.700 | 1.000 | 3 | 2015 | 2018 | |||||||
|
0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||||
|
0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||||
|
0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||||
|
0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||||
|
0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 |
|
0.700 | 1.000 | 3 | 2019 | 2019 | ||||||||
|
0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 |
|
0.700 | 1.000 | 3 | 2019 | 2019 | ||||||||
|
0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 3 | 2019 | 2019 | |||||||
|
0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 |
|
0.700 | 1.000 | 3 | 2019 | 2019 | ||||||||
|
0.689 | 0.400 | 5 | 1296371 | upstream gene variant | A/G | snv | 0.49 |
|
0.700 | 1.000 | 3 | 2019 | 2019 | ||||||||
|
0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 |
|
Neoplasms; Nervous System Diseases | 0.700 | 1.000 | 2 | 2015 | 2017 | |||||||
|
0.595 | 0.560 | 5 | 1279675 | intron variant | C/T | snv | 0.36 |
|
0.700 | 1.000 | 2 | 2018 | 2019 | ||||||||
|
1.000 | 0.080 | 5 | 1279417 | missense variant | C/G | snv |
|
Digestive System Diseases; Neoplasms | 0.700 | 1.000 | 2 | 2013 | 2017 |